Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidates
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 53, Issue 14, Pages 5213-5228Publisher
AMER CHEMICAL SOC
Keywords
Categories
Funding
- Cancer Research UK [CUK] [C309/A8274]
- Breakthrough Breast Cancer Project [AURA 05/06]
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Identification of 5-(3-(methylsulfonyl)phenyl)-3-(4-(methylsulfonyl)phenyl)-3H-imidazo[4,5-b]pyridine as novel orally bioavailable and metabolically stable antimalarial compound for further exploration
Mrinalkanti Kundu, Aditi Dutta, Kuldeep K. Roy, Sajal K. Mal, Shouvik Karmakar, Aritra Mandal, Susanta K. Mondal, Sanjay Kumar, Soumya Saha, Subhankar Pradhan, Ratul Sarkar, Monali Chakrabarti, Pradip K. Malik, Manish Banerjee
CHEMICAL BIOLOGY & DRUG DESIGN (2023)
Discovery of Potent and Orally Bioavailable Pyridine N-Oxide-Based Factor XIa Inhibitors through Exploiting Nonclassical Interactions
Guozhang Xu, Zhijie Liu, Xinkang Wang, Tianbao Lu, Renee L. DesJarlais, Tho Thieu, Jing Zhang, Zheng Huang Devine, Fuyong Du, Qiu Li, Cynthia M. Milligan, Paul Shaffer, Peder E. Cedervall, John C. Spurlino, Christopher F. Stratton, Beth Pietrak, Lawrence M. Szewczuk, Victoria Wong, Ruth A. Steele, Wouter Bruinzeel, Madhu Chintala, Jose Silva, Michael D. Gaul, Mark J. Macielag, Ravi Nargund
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Influence of peripherical modifications in linear and nonlinear photophysical properties of imidazo[4,5-b]pyridine derivatives
O. D. Marbello, A. G. Pelosi, Leandro H. Z. Cocca, J. V. P. Valverde, S. Piguel, L. De Boni, C. R. Mendonca
JOURNAL OF MOLECULAR LIQUIDS (2023)
Dose Number as a Tool to Guide Lead Optimization for Orally Bioavailable Compounds in Drug Discovery
W. Peter Wuelfing, Abdellatif El Marrouni, Maya P. Lipert, Pierre Daublain, Filippos Kesisoglou, Antonella Converso, Allen C. Templeton
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Novel imidazo[4,5-b]pyridine derived acrylonitriles: A combined experimental and computational study of their antioxidative potential
Ida Bocek, Kristina Starcevic, Ivana Novak Jovanovic, Robert Vianello, Marijana Hranjec
JOURNAL OF MOLECULAR LIQUIDS (2021)
Design and Optimization of Novel Benzimidazole- and Imidazo[4,5-b]pyridine-Based ATM Kinase Inhibitors with Subnanomolar Activities
Teodor Dimitrov, Athina Anastasia Moschopoulou, Lennart Seidel, Thales Kronenberger, Mark Kudolo, Antti Poso, Christian Geibel, Pascal Woelffing, Daniel Dauch, Lars Zender, Dieter Schollmeyer, Juergen Bajorath, Michael Forster, Stefan Laufer
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Imidazo[4,5-b]pyridine derived tubulin polymerization inhibitors: Design, synthesis, biological activity in vitro and computational analysis
Ida Bocek, Lucija Hok, Leentje Persoons, Dirk Daelemans, Robert Vianello, Marijana Hranjec
BIOORGANIC CHEMISTRY (2022)
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants
Liu Cao, Yingjun Li, Sidi Yang, Guanguan Li, Qifan Zhou, Jing Sun, Tiefeng Xu, Yang Yang, Ruyan Liao, Yongxia Shi, Yujian Yang, Tiaozhen Zhu, Siyao Huang, Yanxi Ji, Feng Cong, Yinzhu Luo, Yujun Zhu, Hemi Luan, Huan Zhang, Jingdiao Chen, Xue Liu, Renru Luo, Lihong Liu, Ping Wang, Yang Yu, Fan Xing, Bixia Ke, Huanying Zheng, Xiaoling Deng, Wenyong Zhang, Chuwen Lin, Mang Shi, Chun-Mei Li, Yu Zhang, Lu Zhang, Jun Dai, Hongzhou Lu, Jincun Zhao, Xumu Zhang, Deyin Guo
SCIENCE TRANSLATIONAL MEDICINE (2022)
Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment
Jinhua Li, Ting Zhang, Qiong Shi, Gang Lv, Xiaohu Zhou, Namrta Choudhry, Julia Kalashova, Chenglu Yang, Hongmei Li, Yan Long, Balasubramaniyan Sakthivel, Naganna Nimishetti, Hong Liu, Thaddeus D. Allen, Jing Zhang, Dun Yang
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)
Exploring Antimicrobial Features for New Imidazo[4,5-b]pyridine Derivatives Based on Experimental and Theoretical Study
Mohammed-yassin Hjouji, Ahmed M. M. Almehdi, Hicham Elmsellem, Yousra Seqqat, Younes Ouzidan, Mohamed Tebbaa, Noura Ait Lfakir, Youssef Kandri Rodi, Fouad Ouazzani Chahdi, Marwa Chraibi, Kawtar Fikri Benbrahim, Mohamed A. A. Al-Omar, Abdulrahman A. A. Almehizia, Ahmed M. M. Naglah, Shaima A. A. El-Mowafi, Ahmed A. A. Elhenawy
MOLECULES (2023)
Novel amino substituted tetracyclic imidazo[4,5-b]pyridine derivatives: Design, synthesis, antiproliferative activity and DNA/RNA binding study
Borka Loncar, Natasa Perin, Marija Mioc, Ida Bocek, Lea Grgic, Marijeta Kralj, Sanja Tomic, Marijana Radic Stojkovic, Marijana Hranjec
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Insight on a new indolinone derivative as an orally bioavailable lead compound against renal cell carcinoma
Marwa A. Fouad, Mayssoune Y. Zaki, Raghda A. Lotfy, Walaa R. Mahmoud
BIOORGANIC CHEMISTRY (2021)
Synthesis and Biological Activities of Novel 1H-Imidazo[4,5-b]pyridine Derivatives
Jesurajan Jebamani, Shubha Jayachamarajapura Praneshm, Jayadev Shivalingappa, Manjunatha Narayanarao, Mussuvir Pasha, Chandrakant Pawar
CHEMISTRYSELECT (2023)
Synthesis of some new 2-(substituted-phenyl)imidazo[4,5-c] and [4,5-b]pyridine derivatives and their antimicrobial activities
Moftah Altaib, Fatima Doganc, Banu Kaskatepe, Hakan Goker
MOLECULAR DIVERSITY (2023)
Controlling the photoswitching of 2-(4′-diethylamino-2′-hydroxyphenyl)-1H-imidazo-[4,5-b]pyridine by pH
Minati Das, Mongoli Brahma, G. Krishnamoorthy
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY (2021)
Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors
Owen A. Davis, Kwai-Ming J. Cheung, Alfie Brennan, Matthew G. Lloyd, Matthew J. Rodrigues, Olivier A. Pierrat, Gavin W. Collie, Yann-Vai Le Bihan, Rosemary Huckvale, Alice C. Harnden, Ana Varela, Michael D. Bright, Paul Eve, Angela Hayes, Alan T. Henley, Michael D. Carter, P. Craig McAndrew, Rachel Talbot, Rosemary Burke, Rob L. M. van Montfort, Florence Raynaud, Olivia W. Rossanese, Mirco Meniconi, Benjamin R. Bellenie, Swen Hoelder
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Individualized Prediction of Drug Response and Rational Combination Therapy in NSCLC Using Artificial Intelligence-Enabled Studies of Acute Phosphoproteomic Changes
Elizabeth A. Coker, Adam Stewart, Bugra Ozer, Anna Minchom, Lisa Pickard, Ruth Ruddle, Suzanne Carreira, Sanjay Popat, Mary O'Brien, Florence Raynaud, Johann de Bono, Bissan Al-Lazikani, Udai Banerji
MOLECULAR CANCER THERAPEUTICS (2022)
A phase (Ph) I/II trial of the CXCR2 antagonist AZD5069 in combination with enzalutamide (ENZA) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC)
C. Guo, A. Sharp, U. Vogl, I. Colombo, A. Stathis, S. Jain, K. Chandran, C. Tiu, A. Paschalis, R. E. Matthews, I. Figueiredo, J. Rekowski, C. Yap, M. de los Dolores Fenor de la Maza, A. Turner, H. C. Badham, M. Parmar, F. Raynaud, A. Alimonti, J. S. de Bono
ANNALS OF ONCOLOGY (2022)
A Phase I Trial of CT900, a Novel a-Folate Receptor- Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer
Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang, Alvaro Ingles Garces, Andrea Biondo, Ionut-Gabriel Funingana, Martin Little, Ruth Ruddle, Florence Raynaud, Ruth Riisnaes, Bora Gurel, Sue Chua, Nina Tunariu, Joanna C. Porter, Toby Prout, Mona Parmar, Anna Zachariou, Alison Turner, Ben Jenkins, Stuart McIntosh, Ed Ainscow, Anna Minchom, Juanita Lopez, Johann de Bono, Robert Jones, Emma Hall, Natalie Cook, Bristi Basu, Udai Banerji
CLINICAL CANCER RESEARCH (2022)
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays
Olivier A. Pierrat, Manjuan Liu, Gavin W. Collie, Kartika Shetty, Matthew J. Rodrigues, Yann-Vai Le Bihan, Emma A. Gunnell, P. Craig McAndrew, Mark Stubbs, Martin G. Rowlands, Norhakim Yahya, Erald Shehu, Rachel Talbot, Lisa Pickard, Benjamin R. Bellenie, Kwai-Ming J. Cheung, Ludovic Drouin, Paolo Innocenti, Hannah Woodward, Owen A. Davis, Matthew G. Lloyd, Ana Varela, Rosemary Huckvale, Fabio Broccatelli, Michael Carter, David Galiwango, Angela Hayes, Florence Raynaud, Christopher Bryant, Steven Whittaker, Olivia W. Rossanese, Swen Hoelder, Rosemary Burke, Rob L. M. van Montfort
SCIENTIFIC REPORTS (2022)
Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications
Afia Naseem, Akos Pal, Sharon Gowan, Yasmin Asad, Adam Donovan, Csilla Temesszentandrasi-Ambrus, Emese Kis, Zsuzsanna Gaborik, Gurdip Bhalay, Florence Raynaud
CELLS (2022)
Synthesis and Characterization of Griseofulvin Derivatives as Microtubule-Stabilizing Agents
Farhat Firdous, Rida Ibrahim, Muhammad Furqan, Hina Khan, Hadeeqa Raza, Upendra Singh, Abdul-Hamid Emwas, Mariusz Jaremko, Ghayoor Abbas Chotana, Amir Faisal, Rahman Shah Zaib Saleem
CHEMISTRYSELECT (2022)
Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones
Alice C. Harnden, Owen A. Davis, Gary M. Box, Angela Hayes, Louise D. Johnson, Alan T. Henley, Alexis K. de Haven Brandon, Melanie Valenti, Kwai-Ming J. Cheung, Alfie Brennan, Rosemary Huckvale, Olivier A. Pierrat, Rachel Talbot, Michael D. Bright, Hafize Aysin Akpinar, Daniel S. J. Miller, Dalia Tarantino, Sharon Gowan, Selby de Klerk, Peter Craig McAndrew, Yann-Vai Le Bihan, Mirco Meniconi, Rosemary Burke, Vladimir Kirkin, Rob L. M. van Montfort, Florence I. Raynaud, Olivia W. Rossanese, Benjamin R. Bellenie, Swen Hoelder
JOURNAL OF MEDICINAL CHEMISTRY (2023)
HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies
A. Elisa Pasqua, Swee Y. Sharp, Nicola E. A. Chessum, Angela Hayes, Loredana Pellegrino, Michael J. Tucker, Asadh Miah, Birgit Wilding, Lindsay E. Evans, Carl S. Rye, N. Yi Mok, Manjuan Liu, Alan T. Henley, Sharon Gowan, Emmanuel De Billy, Robert te Poele, Marissa Powers, Suzanne A. Eccles, Paul A. Clarke, Florence I. Raynaud, Paul Workman, Keith Jones, Matthew D. Cheeseman
JOURNAL OF MEDICINAL CHEMISTRY (2023)
Machine learning estimation of human body time using metabolomic profiling
Tom Woelders, Victoria L. Revell, Benita Middleton, Katrin Ackermann, Manfred Kayser, Florence I. Raynaud, Debra J. Skene, Roelof A. Hut
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
Christina Guo, Adam Sharp, Bora Gurel, Mateus Crespo, Ines Figueiredo, Suneil Jain, Ursula Vogl, Jan Rekowski, Mahtab Rouhifard, Lewis Gallagher, Wei Yuan, Suzanne Carreira, Khobe Chandran, Alec Paschalis, Ilaria Colombo, Anastasios Stathis, Claudia Bertan, George Seed, Jane Goodall, Florence Raynaud, Ruth Ruddle, Karen E. Swales, Jason Malia, Denisa Bogdan, Crescens Tiu, Reece Caldwell, Caterina Aversa, Ana Ferreira, Antje Neeb, Nina Tunariu, Daniel Westaby, Juliet Carmichael, Maria Dolores Fenor de la Maza, Christina Yap, Ruth Matthews, Hannah Badham, Toby Prout, Alison Turner, Mona Parmar, Holly Tovey, Ruth Riisnaes, Penny Flohr, Jesus Gil, David Waugh, Shaun Decordova, Anna Schlag, Bianca Cali, Andrea Alimonti, Johann S. de Bono
NATURE (2023)
iTAG an optimized IMiD-induced degron for targeted protein degradation in human and murine cells
Habib Bouguenina, Stephanos Nicolaou, Yann-Vai Le Bihan, Elizabeth A. Bowling, Cheyenne Calderon, John J. Caldwell, Brinley Harrington, Angela Hayes, P. Craig Mcandrew, Costas Mitsopoulos, Fernando Jr Sialana, Andrea Scarpino, Mark Stubbs, Arjun Thapaliya, Siddhartha Tyagi, Hannah Z. Wang, Francesca Wood, Rosemary Burke, Florence Raynaud, Jyoti Choudhary, Rob L. M. van Montfort, Amine Sadok, Thomas F. Westbrook, Ian Collins, Rajesh Chopra
ISCIENCE (2023)
Discovery and validation of biomarkers to support clinical development of NXP800: A first-in-class orally active, small-molecule HSF1 pathway inhibitor
P. Workman, P. A. Clarke, R. Te Poele, M. Powers, G. Box, E. De Billy, A. De Haven Brandon, A. Hallsworth, A. Hayes, H. McCann, S. Sharp, M. Valenti, F. I. Raynaud, S. A. Eccles, M. Cheeseman, K. Jones
EUROPEAN JOURNAL OF CANCER (2022)
Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo
A. Harnden, R. Huckvale, K. M. Cheung, O. Davis, O. Pierrat, R. Talbot, G. Box, M. Bright, A. Akpinar, D. Miller, A. Hayes, E. Gunnell, Y. V. Le Bihan, R. Burke, V. Kirkin, R. Van Montfort, F. Raynaud, O. Rossanese, B. Bellenie, S. Hoelder
EUROPEAN JOURNAL OF CANCER (2022)
Investigating the effects of ERAP1 inhibition on antigen presentation and the tumour immune response
A. Margarido, B. Whitton, E. Arwert, M. Cheeseman, A. Kalusa, G. Davison, R. Salimraj, O. Pierrat, M. Richards, H. Dos Santos Costa, P. Meister, A. Hayes, E. Reeves, E. James, R. Burke, F. Raynaud, R. Van Montfort, J. Choudhary, O. Rossanese, G. Newton
EUROPEAN JOURNAL OF CANCER (2022)